StonvexLoading…
StonvexStonvexStonvexCore line items from CWAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $731.37M | $451.80M | $368.17M | $303.43M |
Operating Income | $-7.69M | $12.23M | $-16.75M | $5.12M |
Net Income | $-38.81M | $424.38M | $-21.63M | $-7.97M |
EPS (Diluted) | $-0.14 | $1.68 | $-0.11 | $-0.04 |
Total Assets | $3.03B | $1.17B | $558.74M | $481.94M |
Total Liabilities | $1.00B | $139.34M | $149.09M | $143.56M |
Cash & Equivalents | $91.25M | $177.35M | $221.76M | $250.72M |
Free Cash Flow OCF − CapEx | $164.34M | $69.06M | $78.98M | $50.25M |
Shares Outstanding | 271.32M | 254.36M | 199.69M | 185.56M |